Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Leo Pharma gets rights to a psoriasis drug candidate from ViroBay

Executive Summary

Leo Pharma AS (dermatology) has licensed rights to an oral psoriasis compound from ViroBay Inc. (specializes in the design of protease inhibitors) The preclinical therapeutic is set to begin Phase I studies in the last quarter of this year, and will be tested in patients in early 2013.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R&D and Marketing (Licensing)

Related Companies